Commentary: Let us ponder - Choosing between topical Nepafenac and topical steroids after cataract surgery.
作者信息
Tripathi Amruta S
机构信息
Aarogyam Heart and Eye Clinic, Mumbai, Maharashtra, India.
出版信息
Indian J Ophthalmol. 2022 Mar;70(3):812-813. doi: 10.4103/ijo.IJO_2782_21.
Abstract
摘要
相似文献
1
Commentary: Let us ponder - Choosing between topical Nepafenac and topical steroids after cataract surgery.评论：让我们思考——白内障手术后在局部用奈帕芬酸和局部用类固醇之间进行选择。
Indian J Ophthalmol. 2022 Mar;70(3):812-813. doi: 10.4103/ijo.IJO_2782_21.
2
Prophylaxis of macular edema after cataract surgery in diabetic patients, topical Nepafenac versus intravitreal Ranibizumab.糖尿病患者白内障手术后黄斑水肿的预防：局部用 Nepafenac 与玻璃体内用 Ranibizumab 的比较。
Eur J Ophthalmol. 2022 Jan;32(1):205-212. doi: 10.1177/11206721211001275. Epub 2021 Mar 16.
3
Comparison of preoperative nepafenac (0.1%) and flurbiprofen (0.03%) eye drops in maintaining mydriasis during small incision cataract surgery in patients with senile cataract: A randomized, double-blind study.术前使用萘非那啶（0.1%）和氟比洛芬（0.03%）滴眼液在老年性白内障患者小切口白内障手术中维持瞳孔散大的比较：一项随机双盲研究。
Indian J Pharmacol. 2015 Sep-Oct;47(5):491-5. doi: 10.4103/0253-7613.165201.
4
0.1% Nepafenac reduces pain and increases patient comfort during cataract surgery.0.1% 奈帕芬那滴眼液可减少白内障手术中的疼痛，提高患者舒适度。
Cont Lens Anterior Eye. 2018 Oct;41(5):448-451. doi: 10.1016/j.clae.2018.05.003. Epub 2018 May 26.
5
Comparison of the Effect of Diclofenac 0.1% and Nepafenac 0.1% on Aqueous Flare in Patients Undergoing Cataract Surgery: A Prospective Randomized Study.比较接受白内障手术患者使用双氯芬酸 0.1%和奈帕芬酸 0.1%对房水闪辉的影响：一项前瞻性随机研究。
Curr Eye Res. 2020 Sep;45(9):1089-1093. doi: 10.1080/02713683.2020.1725061. Epub 2020 Feb 4.
6
How does nepafenac affect the choroidal thickness after uneventful cataract surgery?在白内障手术顺利完成后，萘非那酮对脉络膜厚度有何影响？
Eur J Ophthalmol. 2021 Sep;31(5):2319-2328. doi: 10.1177/1120672120976041. Epub 2020 Nov 29.
7
Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac.眼部渗透与视网膜炎症抑制：关于萘非那酮临床效用的数据及专家意见审视
Curr Med Res Opin. 2006 Feb;22(2):397-404. doi: 10.1185/030079906X89775.
8
Comparison of the efficacy and patients' tolerability of Nepafenac and Ketorolac in the treatment of ocular inflammation following cataract surgery: A meta-analysis of randomized controlled trials.奈帕芬胺与酮咯酸治疗白内障手术后眼部炎症的疗效及患者耐受性比较：一项随机对照试验的荟萃分析。
PLoS One. 2017 Mar 2;12(3):e0173254. doi: 10.1371/journal.pone.0173254. eCollection 2017.
9
Cystoid and diabetic macular edema treated with nepafenac 0.1%.用0.1%萘哌地尔治疗囊样黄斑水肿和糖尿病性黄斑水肿。
J Ocul Pharmacol Ther. 2007 Dec;23(6):585-90. doi: 10.1089/jop.2007.0062.
10
Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies.白内障手术后糖尿病视网膜病变患者应用 0.3% 奈帕芬胺：两项随机 3 期研究结果。
Ophthalmology. 2017 Jun;124(6):776-785. doi: 10.1016/j.ophtha.2017.01.036. Epub 2017 Mar 6.
本文引用的文献
1
Comparison of once daily dose of 0.3% nepafenac alone and three times dose of 0.1% nepafenac alone in pain and inflammation control after phacoemulsification.白内障超声乳化术后每日一次 0.3% 尼非帕芬和三次 0.1% 尼非帕芬单独使用在疼痛和炎症控制方面的比较。
Indian J Ophthalmol. 2022 Mar;70(3):807-812. doi: 10.4103/ijo.IJO_2401_21.
2
Comparison between 0.1% Nepafenac and 1% Prednisolone Eye Drop in Postoperative Management Following Micro-incisional Cataract Surgery.0.1%尼泊非那胺与 1%泼尼松龙滴眼液在白内障超声乳化术后管理中的比较。
Korean J Ophthalmol. 2021 Jun;35(3):188-197. doi: 10.3341/kjo.2020.0135. Epub 2021 Jun 4.
3
Management of macular oedema in diabetic patients undergoing cataract surgery.糖尿病患者白内障手术中黄斑水肿的管理
Curr Opin Ophthalmol. 2017 Jan;28(1):23-28. doi: 10.1097/ICU.0000000000000328.
4
Risk Factors and Incidence of Macular Edema after Cataract Surgery: A Database Study of 81984 Eyes.白内障手术后黄斑水肿的风险因素和发生率：81984 只眼的数据库研究。
Ophthalmology. 2016 Feb;123(2):316-323. doi: 10.1016/j.ophtha.2015.10.001. Epub 2015 Dec 8.
5
Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review.用于眼科的局部用非甾体抗炎药：安全性综述。
Drug Saf. 2002;25(4):233-50. doi: 10.2165/00002018-200225040-00002.
6
Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy.奈帕芬酸，一种具有独特潜在效用的非甾体前体药物，可用于治疗创伤性眼部炎症：I. 抗炎疗效评估
Inflammation. 2000 Aug;24(4):357-70. doi: 10.1023/a:1007049015148.
7
Nonsteroidal anti-inflammatory drugs and cataract surgery.
Arch Ophthalmol. 1994 Jul;112(7):891-4. doi: 10.1001/archopht.1994.01090190039018.
Zotero 插件